What does this TikTok video claim?
@keepingrosieaccountable shares that she's lost 3.5 stone (49 pounds) using Mounjaro for weight loss while managing PCOS. She frames this as progress on a longer weight loss journey.
The video is refreshingly straightforward. No wild promises about miracle cures or dramatic before-and-after transformations. Rosie simply documents her weight loss progress and acknowledges she has more work ahead.
Her mention of PCOS is relevant since this condition affects 6-12% of women of reproductive age and often makes weight management more challenging due to insulin resistance and hormonal imbalances.
Is losing 49 pounds on tirzepatide realistic?
Yes, this amount of weight loss matches clinical trial data for tirzepatide (Mounjaro's active ingredient). The SURMOUNT-1 trial found average weight loss of 22.5% with the 15mg dose over 72 weeks.
For context, that's roughly 45-67 pounds for someone starting at 200-300 pounds. Rosie's 49-pound loss fits well within this range, though we don't know her timeline or starting weight.
The trial data shows most weight loss occurs in the first 36-52 weeks, with the medication working through GLP-1 and GIP receptor activation to slow gastric emptying and reduce appetite. About 91% of participants lost at least 5% of their body weight.
Does PCOS affect how well Mounjaro works?
Women with PCOS may actually see enhanced benefits from GLP-1 medications like tirzepatide. A 2023 study in Diabetes Care found that liraglutide improved insulin sensitivity and menstrual regularity in PCOS patients.
PCOS creates insulin resistance that makes traditional weight loss methods less effective. GLP-1 receptor agonists directly address this insulin resistance while also reducing appetite.
However, no large-scale trials have specifically tested tirzepatide in PCOS populations. The evidence comes from smaller studies with other drugs in this class, so we're extrapolating somewhat.
What's missing from this success story?
Rosie doesn't mention timeline, which matters enormously for evaluating her results. Losing 49 pounds over six months is very different from losing it over two years.
She also doesn't discuss side effects, which affect most people starting tirzepatide. The SURMOUNT-1 trial reported nausea in 29% of participants and vomiting in 13%. About 7% dropped out due to side effects.
The "long way to go" comment suggests she's targeting additional significant weight loss. While tirzepatide can support this, the medication works best alongside lifestyle changes that she doesn't detail here.
Should you expect similar results?
Rosie's results are encouraging but not guaranteed for everyone. Individual responses to tirzepatide vary widely based on genetics, adherence, starting weight, and lifestyle factors.
The medication requires weekly injections and typically costs $900-1,200 monthly without insurance coverage. Most people need to stay on it long-term to maintain weight loss.
If you have PCOS and struggle with weight management, tirzepatide represents a legitimate medical option worth discussing with your doctor. Just don't expect identical results to what you see on social media.